JMY and neoplasm: Given that JMY reduced DNA damage accumulation, increased resistance to chemotherapeutic drugs, and reduced overall mutation count, we hypothesised that tumours with higher JMY expression might exhibit a more aggressive phenotype resulting in poorer patient survival.